{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:20:23Z","timestamp":1782123623456,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The optimal management of borderline ovarian tumors (BOTs), particularly the safety and efficacy of <jats:italic>in vitro<\/jats:italic> fertilization (IVF) following fertility-sparing surgery (FSS), remains controversial. This study aimed to evaluate the impact of controlled ovarian stimulation (COS) on oncofertility outcomes in infertile women with BOT after FSS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective observational study was conducted at the Reproductive Medical Center, Peking University Third Hospital (Beijing, China) and included 73 infertile BOT patients who underwent IVF between January 2008 and June 2022.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median follow-up was 61.0 months (range: 7.0\u2013156.0 months). The BOT recurrence rate was 20.5% (15\/73), and the cumulative live birth rate per patient was 57.5% (42\/73). There were no significant differences in the number of COS cycles (<jats:italic>P<\/jats:italic>=0.513) or total dose of gonadotropin (Gn) (<jats:italic>P<\/jats:italic> =0.183) between the recurrence and non-recurrence groups. Multivariate analysis identified three independent predictors of oncologic outcomes: interval from surgery to first IVF (HR: 0.07; 95% CI: 0.01\u20130.44; <jats:italic>P<\/jats:italic> =0.004), duration of Gn administration (HR: 9.70; 95% CI: 1.37\u201368.70; <jats:italic>P<\/jats:italic> =0.023), and live birth (HR: 7.02; 95% CI: 1.35\u201336.41; <jats:italic>P<\/jats:italic>=0.020).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In infertile BOT patients undergoing FSS, IVF significantly improves pregnancy outcomes. COS can be safely conducted post-FSS without increasing recurrence risk, provided initiation is delayed \u22653 months postoperatively and Gn administration is limited to \u226413 days.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1592600","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:37Z","timestamp":1759119157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncofertility outcomes after fertility-sparing surgery in infertile BOT patients: results of a large retrospective study on controlled ovarian stimulation"],"prefix":"10.3389","volume":"15","author":[{"given":"Liang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Mei","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20080","article-title":"Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis","volume":"100","author":"Sherman","year":"2004","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.021","article-title":"Conservative surgery for borderline ovarian tumors: a review","volume":"100","author":"Tinelli","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.01.004","article-title":"Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk","volume":"51","author":"Vasconcelos","year":"2015","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gofs.2020.01.013","article-title":"Borderline ovarian tumours: CNGOF guidelines for clinical practice - epidemiology and risk factors of relapse, follow-up and interest of a completion surgery","volume":"48","author":"Margueritte","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(03)00160-2","article-title":"Safety of conservative management and fertility outcome in women with borderline tumors of the ovary","volume":"79","author":"Donnez","year":"2003","journal-title":"Fertility Sterility"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.07.029","article-title":"Borderline tumours of the ovary and fertility","volume":"42","author":"Morice","year":"2006","journal-title":"Eur J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101961","article-title":"Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group","volume":"50","author":"Sangnier","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7150\/jca.56387","article-title":"Analysis of factors influencing relapse and pregnancy in patients with borderline ovarian tumors","volume":"12","author":"Qi","year":"2021","journal-title":"J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw090","article-title":"Management of borderline ovarian tumors","author":"du Bois","year":"2016","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Darai","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctrv.2016.06.010","article-title":"Fertility preservation in women with borderline ovarian tumours","volume":"49","author":"Mangili","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.fertnstert.2004.10.009","article-title":"Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study","volume":"83","author":"Fauvet","year":"2005","journal-title":"Fertility Sterility"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.12.029","article-title":"Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience","volume":"269","author":"Sobiczewski","year":"2022","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1804-7","article-title":"Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience","volume":"284","author":"Kanat-Pektas","year":"2011","journal-title":"Arch Gynecol Obstetrics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000497203","article-title":"Live Births after in vitro Fertilization with Fertility-Sparing Surgery for Borderline Ovarian Tumors: A Case Series and Literature Review","volume":"84","author":"Li","year":"2019","journal-title":"Gynecologic Obstetric Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.09.012","article-title":"Fertility preservation in gynecologic cancers","volume":"155","author":"Taylan","year":"2019","journal-title":"Gynecol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.07.1503","article-title":"Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study","volume":"87","author":"Fortin","year":"2007","journal-title":"Fertility Sterility"},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ygyno.2019.12.046","article-title":"Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group","volume":"157","author":"Chevrot","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex352","article-title":"Safety of ovarian tissue transplantation in patients with borderline ovarian tumors","volume":"33","author":"Masciangelo","year":"2018","journal-title":"Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/cancers14061485","article-title":"Fertility sparing surgery and borderline ovarian tumours","volume":"14","author":"Kasaven","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2015.26.4.343","article-title":"Controversies in borderline ovarian tumors","volume":"26","author":"Seong","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del301","article-title":"Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours","volume":"21","author":"Basille","year":"2006","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000316264","article-title":"Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery","volume":"70","author":"Denschlag","year":"2010","journal-title":"Gynecologic Obstetric Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.beem.2018.10.002","article-title":"Pharmacology of medications used for ovarian stimulation","volume":"33","author":"Quaas","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B26","unstructured":"Ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer,Version 2\n          \n          \n          \n          2023"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.12.006","article-title":"Borderline ovarian tumours","volume":"26","author":"Trope","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.11.428","article-title":"Advances in fertility preserving surgery for borderline ovarian tumors","volume":"270","author":"Wang","year":"2022","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-016-0226-y","article-title":"Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience","volume":"9","author":"Chen","year":"2016","journal-title":"J Ovarian Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2016.03.018","article-title":"Pregnancy after fertility-sparing surgery for borderline ovarian tumors","volume":"134","author":"Lian","year":"2016","journal-title":"Int J Gynaecol Obstetrics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100756","article-title":"Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population","volume":"36","author":"Kumari","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000014957","article-title":"Laparoscopic surgery: Any role in patients with unexplained infertility and failed in vitro fertilization cycles","volume":"98","author":"Yu","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu297","article-title":"Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study","volume":"30","author":"Bjornholt","year":"2015","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1592600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:40Z","timestamp":1759119160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1592600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":33,"alternative-id":["10.3389\/fonc.2025.1592600"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1592600","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1592600"}}